SNMMI Begins Release of Appropriate Use Criteria for High-Value Nuclear Medicine Procedures

SNMMI has released a new appropriate use criteria (AUC) for bone scintigraphy in prostate and breast cancer, the two most common diagnoses for which bone scans are ordered in the adult population.

This is the first in a series of new AUC developed by SNMMI in its role as a qualified provider-led entity (PLE) under the Medicare Appropriate Use Criteria Program for advanced diagnostic imaging. These AUC are intended to assist referring physicians and ordering professionals to fulfill the requirements of the 2014 Protecting Access to Medicare Act (PAMA).

For the complete text of the bone scintigraphy AUC, click here; a summary with excerpts is published in the April issue of The Journal of Nuclear Medicine.

For the bone scintigraphy AUC, the workgroup was composed of representatives from SNMMI, the European Association of Nuclear Medicine (EANM), and the American Society of Clinical Oncology (ASCO).

To read more please visit https://www.snmmi.org/NewsPublications/NewsDetail.aspx?ItemNumber=23301

Source: Society of Nuclear Medicine and Molecular Imaging